Allergy medication for hypertension requires careful selection, as some of the most widely used allergy remedies can raise blood pressure or undermine antihypertensive treatment. In the UK, millions of people live with both allergic conditions — such as hay fever, urticaria, or allergic asthma — and high blood pressure, making treatment choices particularly important. Certain decongestants found in common over-the-counter cold and allergy products pose a real cardiovascular risk, whilst other options, including second-generation antihistamines and intranasal corticosteroids, are generally considered safe. This guide explains which allergy treatments are appropriate, which to avoid, and when to seek professional advice.

Managing Allergies When You Have High Blood Pressure

Living with both allergies and high blood pressure (hypertension) presents a particular challenge, as some of the most commonly used allergy medications can interfere with blood pressure control. Allergic conditions — including hay fever (allergic rhinitis), urticaria, and allergic asthma — are widespread in the UK, affecting millions of people across all age groups. When these individuals also have hypertension, choosing the right treatment requires careful consideration.

Hypertension is defined by NICE guideline NG136 as a clinic blood pressure of 140/90 mmHg or above, confirmed by ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM). Stage 1 hypertension is confirmed by an ABPM or HBPM daytime average of 135/85 mmHg or above; stage 2 is 150/95 mmHg or above. Hypertension is one of the leading risk factors for cardiovascular disease in the UK, and managing it effectively often involves lifestyle changes and medication. Introducing allergy treatments that raise blood pressure — even modestly — can undermine this management.

Important: If your blood pressure reading is 180/120 mmHg or higher, seek same-day medical assessment. If you also experience chest pain, sudden breathlessness, severe headache, visual disturbance, or any neurological symptoms (such as weakness, slurred speech, or facial drooping), call 999 immediately, as these may indicate a hypertensive emergency requiring urgent treatment.

If you have hypertension, using a validated home blood pressure monitor and sharing your readings with your GP or pharmacist can help ensure your condition remains well controlled, particularly when starting any new medication.

The good news is that safe and effective options do exist. With the right guidance from a GP or pharmacist, people with hypertension can manage their allergy symptoms without compromising their cardiovascular health. Understanding which medications are appropriate, and which should be avoided, is the first step towards making informed decisions about your care.

Which Allergy Medications Are Safe With Hypertension?

Several allergy medications are generally considered safe for people with high blood pressure, provided they are used as directed and any underlying hypertension is well controlled.

Second-generation antihistamines are typically the first-line recommendation for allergic rhinitis and urticaria. These include:

• Cetirizine

• Loratadine

• Fexofenadine

Unlike older, first-generation antihistamines, these medications do not significantly affect blood pressure at licensed doses and are less likely to cause sedation. They work by selectively blocking peripheral H1 histamine receptors, reducing symptoms such as sneezing, itching, and a runny nose without stimulating the cardiovascular system. However, some people may still experience mild drowsiness; if this occurs, do not drive or operate machinery, and seek advice from your pharmacist.

Intranasal corticosteroid sprays — such as fluticasone propionate and beclometasone dipropionate — are also considered safe and are recommended by NICE (CKS: Allergic rhinitis) as a first-line treatment for moderate-to-severe allergic rhinitis. Because they act locally within the nasal passages with minimal systemic absorption at recommended doses, they do not raise blood pressure and are suitable for long-term use. If you are taking certain medicines that affect liver enzymes — such as ritonavir or cobicistat — check the patient information leaflet (PIL) or ask your pharmacist, as interactions are possible with some formulations.

Sodium cromoglicate nasal sprays or eye drops may also be used safely in hypertensive patients for localised allergic symptoms. These act as mast cell stabilisers, preventing the release of histamine and other inflammatory mediators. Note that sodium cromoglicate often requires dosing up to four times daily and may take several days of regular use before its full benefit is felt; it is therefore most effective when started before the allergy season begins.

Non-pharmacological measures — including saline nasal irrigation and allergen avoidance — are safe adjuncts for all patients, including those with hypertension, and can provide meaningful symptomatic relief without any cardiovascular risk.

Always read the patient information leaflet and consult a pharmacist if you are unsure whether a specific formulation is appropriate for your circumstances. If you experience any suspected side effects from an allergy medication, you can report these via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Allergy Treatments to Avoid If You Have High Blood Pressure

Certain allergy medications carry a meaningful risk of raising blood pressure and should generally be avoided — or used only under medical supervision — in people with hypertension.

Oral decongestants are the most significant concern. Medicines containing pseudoephedrine or phenylephrine — commonly found in combination cold and allergy remedies — work by constricting blood vessels to reduce nasal congestion. This same mechanism can raise systemic blood pressure and increase heart rate, potentially destabilising blood pressure control in hypertensive patients. In 2024, the MHRA strengthened safety warnings for pseudoephedrine, highlighting a risk of serious but rare vascular conditions including posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). People with hypertension, heart disease, or thyroid conditions are advised to seek medical advice before using any product containing these ingredients.

Topical (nasal) decongestants — such as xylometazoline and oxymetazoline, available in many over-the-counter nasal sprays — can also cause systemic vasoconstriction, particularly if used excessively. They should be limited to a maximum of 3–7 days' continuous use. Prolonged use can lead to rhinitis medicamentosa (rebound congestion), a condition in which the nasal passages become more congested when the spray is stopped, creating a cycle of dependency. People with hypertension should use topical decongestants with caution and only after seeking pharmacist advice.

These decongestant ingredients are often found in:

• Combined 'day and night' cold and flu tablets

• Multi-symptom allergy relief products

• Over-the-counter sinus relief preparations

It is also important to be aware that many combination cold and flu products contain additional ingredients that may be unsuitable for people with hypertension, including non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen — which can raise blood pressure and reduce the effectiveness of some antihypertensive medicines — and caffeine, which may also have a transient pressor effect. Always read the full ingredients list before purchasing any combination product.

Monoamine oxidase inhibitors (MAOIs): If you are taking an MAOI (used for depression or other conditions), you must not use any product containing pseudoephedrine or phenylephrine, as the combination can cause a dangerous and potentially life-threatening rise in blood pressure. Check the BNF or ask your pharmacist or GP if you are unsure.

First-generation antihistamines, such as chlorphenamine and promethazine, do not directly raise blood pressure. However, they have significant sedating and anticholinergic properties, which can increase the risk of dizziness, confusion, and falls — particularly in older adults. Their sedating effects may be compounded by other medicines that act on the central nervous system, including alcohol, benzodiazepines, opioids, and some alpha-blockers used to treat hypertension. For these reasons, first-generation antihistamines are generally less suitable for many patients managing cardiovascular conditions.

Always inform your pharmacist or GP about your hypertension diagnosis before purchasing any over-the-counter allergy remedy, as many combination products contain ingredients that may not be appropriate for you.

How Decongestants and Antihistamines Affect Blood Pressure

Understanding the pharmacological mechanisms behind allergy medications helps explain why some are safer than others for people with hypertension.

Oral decongestants such as pseudoephedrine and phenylephrine are sympathomimetic agents — they mimic the effects of adrenaline (epinephrine) by stimulating alpha-adrenergic receptors in blood vessel walls. This causes vasoconstriction, which reduces nasal swelling and congestion. However, this vasoconstriction is not limited to the nasal mucosa; it can occur systemically, potentially leading to:

• Elevated systolic and diastolic blood pressure

• Increased heart rate

• Reduced effectiveness of some antihypertensive medicines, including beta-blockers and methyldopa

It is worth noting that phenylephrine's oral bioavailability is variable and its blood pressure effects may be less pronounced than those of pseudoephedrine; however, MHRA and BNF cautions apply to both, and neither should be used without medical advice in people with hypertension. For individuals whose blood pressure is already elevated or poorly controlled, even a short course of oral decongestants can pose a risk.

Topical nasal decongestants (xylometazoline, oxymetazoline) act via the same alpha-adrenergic mechanism. Although systemic absorption is generally lower than with oral preparations, it is not negligible — particularly with frequent or prolonged use. As noted above, use beyond 3–7 days risks rhinitis medicamentosa (rebound congestion).

Second-generation antihistamines act selectively on peripheral H1 receptors and do not stimulate adrenergic pathways. They have no clinically significant effect on blood pressure at standard therapeutic doses, though mild drowsiness is possible in some individuals.

First-generation antihistamines have broader receptor activity, including anticholinergic effects, which can cause dry mouth, urinary retention, and sedation. They do not typically raise blood pressure directly. However, their sedating properties can add to the CNS-depressant effects of other medicines — including alcohol, benzodiazepines, opioids, and some alpha-blockers — increasing the risk of dizziness, postural hypotension, and falls. This is a particular concern in older adults.

Intranasal corticosteroids work through a completely different mechanism — suppressing local inflammatory responses in the nasal mucosa — and have negligible systemic cardiovascular effects when used at recommended doses, making them a particularly suitable option for hypertensive patients.

If you suspect a medicine is affecting your blood pressure, monitor your readings at home and discuss them with your GP or pharmacist. Any suspected side effects can be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Speaking to Your GP or Pharmacist About Safe Options

If you have hypertension and are experiencing allergy symptoms, speaking to your GP or a community pharmacist before starting any new medication is strongly advised. Both are well placed to review your current antihypertensive regimen and recommend allergy treatments that will not interfere with your blood pressure management.

When to seek urgent or emergency help:

• Call 999 immediately if you experience difficulty breathing, swelling of the throat, tongue, or lips, or collapse — these may be signs of anaphylaxis, which is a medical emergency.

• Call 999 if you develop chest pain, sudden severe headache, visual disturbance, or neurological symptoms (weakness, slurred speech, facial drooping), as these may indicate a hypertensive emergency or stroke.

• Seek same-day medical assessment if your blood pressure reading is 180/120 mmHg or higher, even without symptoms.

• If you are taking an ACE inhibitor (such as ramipril or lisinopril) and develop new swelling of the face, lips, or tongue, seek urgent medical attention, as this may indicate ACE inhibitor-related angioedema.

When to contact your GP:

• If your allergy symptoms are severe, persistent, or significantly affecting your quality of life

• If over-the-counter antihistamines are not providing adequate relief

• If you are considering allergen immunotherapy (desensitisation) as a long-term treatment — note that patients taking beta-blockers or ACE inhibitors may require specialist assessment before starting immunotherapy

• If you notice a rise in your blood pressure readings after starting a new allergy medication

Your pharmacist can help by:

• Reviewing the ingredients of over-the-counter products to identify any decongestants, NSAIDs, caffeine, or other contraindicated substances

• Recommending appropriate antihistamines or nasal sprays based on your medical history

• Checking for interactions with your existing medications

Community pharmacists can provide advice and supply appropriate over-the-counter treatments for allergic rhinitis. In England, the NHS Pharmacy First service allows patients to receive clinical assessment and treatment for a defined set of conditions without a GP appointment; however, allergic rhinitis is not currently among the seven Pharmacy First England clinical pathways (as of 2024). Service scope may vary across the UK nations — your pharmacist can advise on what is available locally.

Always bring a list of your current medications — including any supplements — and your recent home blood pressure readings to any consultation, as this helps clinicians and pharmacists make the safest recommendations for your individual circumstances. Any suspected side effects from allergy medicines should be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

NICE and NHS Guidance on Allergy Care for Hypertensive Patients

NICE and the NHS provide clear frameworks for managing both allergic conditions and hypertension, and these guidelines inform best practice across primary and secondary care in the UK.

For allergic rhinitis, NICE Clinical Knowledge Summary (CKS: Allergic rhinitis) recommends intranasal corticosteroids as the most effective first-line treatment for moderate-to-severe symptoms, with second-generation antihistamines as an alternative or adjunct for milder presentations. Crucially, NICE does not recommend oral decongestants as a routine treatment for allergic rhinitis, which aligns with the safety concerns relevant to hypertensive patients. The NHS hay fever guidance (nhs.uk) similarly advises patients with high blood pressure to avoid decongestant-containing cold and allergy remedies and to opt for antihistamines or saline nasal rinses instead.

For hypertension, NICE guideline NG136 (Hypertension in adults: diagnosis and management) outlines a structured approach to diagnosis — including confirmation with ABPM or HBPM — and management, emphasising the importance of avoiding medications, including over-the-counter products, that may raise blood pressure or reduce the effectiveness of antihypertensive therapy. Patients are encouraged to discuss all medications, including those purchased without a prescription, with their healthcare team.

The MHRA (Medicines and Healthcare products Regulatory Agency) requires that products containing pseudoephedrine and phenylephrine carry clear warnings advising people with hypertension, heart disease, or thyroid conditions to seek medical advice before use. In 2024, the MHRA issued a Drug Safety Update strengthening warnings for pseudoephedrine, highlighting a risk of serious vascular conditions including posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). These warnings are printed on packaging and patient information leaflets, and are reflected in BNF monographs for these medicines.

Saline nasal irrigation — a simple, non-pharmacological option — can provide symptomatic relief from nasal congestion without any cardiovascular risk, and may be a useful adjunct for hypertensive patients seeking additional comfort during allergy season.

If you experience any suspected side effects from an allergy or blood pressure medicine, you can report these to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk. Always read the patient information leaflet supplied with your medicine.

Key references:

• NICE NG136: Hypertension in adults: diagnosis and management (nice.org.uk)

• NICE CKS: Allergic rhinitis (cks.nice.org.uk)

• NHS: Hay fever (nhs.uk)

• NHS: Decongestants (nhs.uk)

• NHS: High blood pressure (hypertension) (nhs.uk)

• MHRA Drug Safety Update 2024: Pseudoephedrine

• British National Formulary (BNF): monographs for pseudoephedrine, phenylephrine, xylometazoline, oxymetazoline (bnf.nice.org.uk)

Frequently Asked Questions